Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v5-FR
Language English French
Date Updated 2017-09-07 2017-09-06
Drug Identification Number 02361817 02361817
Brand name BYETTA BYETTA
Common or Proper name exenatide injection exenatide injection
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients EXENATIDE EXENATIDE
Strength(s) 250MCG 250MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2.4 mL prefilled pen 2.4 mL prefilled pen
ATC code A10BJ A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-08-14 2017-08-14
Actual start date
Estimated end date 2017-09-04 2017-09-04
Actual end date 2017-09-06 2017-09-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments